US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 41.110
  • +2.860+7.48%
Close Nov 22 16:00 ET
  • 41.330
  • +0.220+0.54%
Post 20:01 ET
15.82BMarket Cap-7075P/E (TTM)

Moderna Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Moderna Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.25B
1.86B
+615.03M
Beat Est.
-31.90%
+1.69%
+49.32%
EPS
-1.93
0.03
+1.96
Beat Est.
+79.74%
+100.31%
+101.55%
Analyst Rating
Hold

Nov 24, 2024

Moderna Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 235.090M--
--2024/Q4-- / 1.026B--
Nov 7, 20242024/Q31.862B / 1.247B--
Aug 1, 20242024/Q2241.000M / 134.872M--
May 2, 20242024/Q1167.000M / 125.328M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 235.090M--
--2024/Q4-- / 1.026B--
Nov 7, 20242024/Q31.862B / 1.247B--
Aug 1, 20242024/Q2241.000M / 134.872M--
May 2, 20242024/Q1167.000M / 125.328M--

Unlock Free Earnings Estimates

Moderna Earnings Reports

  • Moderna | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:11 ET

  • Moderna | 8-K: Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 7 06:38 ET

  • Moderna | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:10 ET

  • Moderna | 8-K: Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 1 06:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Hold

    • Buy

      30.00%

    • Hold

      60.00%

    • Sell

      10.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.43%